Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network-Reference-Cited by-同舟云学术

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network

Published:2018-04-17 Issue:11 Volume:47 Page:1511-1522
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Flamm S. L.¹,Bacon B.²,Curry M. P.³^ORCID,Milligan S.⁴,Nwankwo C. U.⁵,Tsai N.⁶,Younossi Z.⁷^ORCID,Afdhal N.³

Affiliation:

1. Northwestern University Feinberg School of Medicine; Chicago IL USA

2. Saint Louis University School of Medicine; St. Louis MO USA

3. Beth Israel Deaconess Medical Center; Boston MA USA

4. Trio Health Analytics; La Jolla CA USA

5. Merck & Co., Inc.; Kenilworth NJ USA

6. Queens Medical Center; University of Hawaii; Honolulu HI USA

7. Department of Medicine; Center for Liver Diseases; Inova Fairfax Hospital; Falls Church VA USA

Funder

Merck

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14635/fullpdf

Reference19 articles.

1. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010;Denniston;Ann Intern Med,2014

2. Hepatitis C infection: a multi-faceted systemic disease with clinical, patient reported and economic consequences;Younossi;J Hepatol,2016

3. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more;Pearlman;Clin Infect Dis,2011

4. American Association for the Study of Liver Diseases and Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C http://www.hcvguidelines.org/

5. Treating hepatitis C in patients with renal failure;Lens;Dig Dis,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance;Annals of Hepatology;2023-03

2. An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study);Health Science Reports;2022-12-05

3. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective;Journal of Managed Care & Specialty Pharmacy;2022-10

4. An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease;Pathogens;2021-10-26

5. EASL recommendations on treatment of hepatitis C: Final update of the series☆;Journal of Hepatology;2020-11